During the past decade, Policlinico Duilio Casula, AOU Cagliari conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico Duilio Casula, AOU Cagliari" #1 sponsor was "University of Cagliari" with 9 trials, followed by "Amgen" with 3 trials sponsored, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "University of Campania "Luigi Vanvitelli"" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Duilio Casula, AOU Cagliari" #1 collaborator was "Istituto Nazionale Tumori di Napoli" with 1 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator, "Niguarda Hospital" with 1 trials as a collaborator and "Unità Sperimentazioni cliniche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Duilio Casula, AOU Cagliari" are "Anesthesia" (2 trials), "Advanced Colorectal Cancer" (1 trials), "Chronic Hepatitis c" (1 trials), "Cognitive Impairment" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Policlinico Duilio Casula, AOU Cagliari" in a lesser frequency.

Most popular intervention types in "Policlinico Duilio Casula, AOU Cagliari" are "Drug" (10 trials), "Other" (4 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Docetaxel" (2 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Duilio Casula, AOU Cagliari" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Duilio Casula, AOU Cagliari". 4 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Policlinico Duilio Casula, AOU Cagliari, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Duilio Casula, AOU Cagliari, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".